Investigation of G q signalling with pharmacological agonists of G q -coupled receptors lacks spatio-temporal precision. The aim of this study was to establish melanopsin, a light-sensitive G q -coupled receptor, as a new tool for the investigation of spatial and temporal effects of G q stimulation on pacemaking in cardiomyocytes at an early developmental stage.
Introduction
The G q -signalling pathway integrates diverse extracellular stimuli into intracellular responses. A huge variety of neurotransmitters and hormones activate G q protein-coupled receptors leading to stimulation of phospholipase C-b (PLC-b) via the Ga subunit of the heterotrimeric G q protein. PLC-b catalyses the hydrolysis of the membrane phospholipid phosphatidylinositol-4,5-bisphosphate producing the second messengers inositol-1,4,5-trisphosphate (IP 3 ) and diacylglycerol. IP 3 binds to IP 3 receptors in the endoplasmatic or sarcoplasmatic reticulum and thereby initiates the release of Ca 2+ from intracellular stores. Diacylglycerol leads to activation of protein kinase C, but can also activate canonical transient receptor potential channels, which lead to Ca 2+ entry into the cell ( Figure 1A ).
-3
The G q -signalling cascade plays an important role in diverse physiological and pathological conditions of the heart. 4, 5 In the developing cardiomyocytes, IP 3 mediates cyclic intracellular Ca 2+ release that is involved in the initiation and regulation of spontaneous electrical activity. [6] [7] [8] [9] [10] receptors are also expressed in the adult sinus node of mice and application of G q -coupled agonists, or IP 3 causes an increase of firing rate indicating the contribution of the G q -signalling cascade to pacemaking of the adult heart. 11, 12 Furthermore, G q signalling seems to play a role in the generation of arrhythmias in atrial and ventricular cardiomyocytes. 5, 13, 14 In addition to these acute effects, sustained activation of G q protein-coupled receptors by endothelin-1 (ET-1) or phenylephrine has been shown to cause cardiomyocyte hypertrophy. 5, 15 For the investigation of G q signalling, it is necessary to identify G q -coupled receptors in the cell type of interest and to activate these by application of specific agonists. However, with the currently available methods, the analysis of temporal and spatial aspects of G q signalling is technically limited because of non-localized and delayed action of agonists in vitro as well as in vivo. We propose that optogenetic G q activation is a novel tool to investigate G q signalling in the cardiovascular system with high temporal and spatial resolution.
Optogenetics is a technology that combines the expression of lightsensitive proteins with stimulation of cells and organs by light, and can be used in vitro as well as in vivo. 16, 17 Optogenetic stimulation allows a very high spatio-temporal resolution because light can be focused to specific regions using lenses or light guides, and the exact time of activation and deactivation is defined by onset and duration of illumination. By expression of optogenetic proteins with specific promoters, light can be used for cell type-specific stimulation. The most frequently used optogenetic protein is channelrhodopsin2, a light-gated non-selective cation channel. 17 We have shown that optogenetic stimulation can be used to induce and prolong action potentials in channelrhodopsin2-expressing cardiomyocytes in vitro, and for atrial and ventricular pacing as well as arrhythmia induction in vivo. 16 For optical stimulation of G proteins, light-sensitive receptors are required. It has previously been demonstrated that a chimeric protein consisting of rhodopsin and the a 1 -adrenergic receptor (optoa 1 -AR) can be used for light-induced G q activation and modulation of spike firing in neurons in vivo. 18 Another light-activated G q -coupled receptor is melanopsin, which is expressed in photosensitive ganglion cells of the retina and is involved in the regulation of circadian rhythm and pupillary light reflexes. 19 -21 Melanopsin was used before for optogenetic modulation of blood glucose homeostasis in diabetic mice by light-induced production and secretion of glucagon-like peptide 1 in artificial engineered and transplanted HEK293 cells. 22 The aim of this study was to show that optogenetic G q activation can be performed in cardiomyocytes to modulate their physiological functions. We have therefore generated melanopsin-expressing cardiomyocytes and investigated effects of light-induced G q activation on spontaneous beating and local pacemaking. We found that melanopsin allows local and fast G q activation with very low light intensities, and we believe that melanopsin is a useful new optogenetic tool for cardiovascular research.
Methods
An expanded Methods section is available in Supplementary material online.
Vector construction and analysis in HEK293FT cells
For construction of the CAG-melanopsin-IRES-green fluorescence protein (GFP) expression plasmid, melanopsin-IRES-GFP was excised from the pIRES 2 -OPN4AI plasmid 21 (kindly provided by I. Provencio, University of Virginia) and cloned into an expression plasmid with the chicken b-actin (CAG) promoter as described before. 16 Ca 2+ imaging of transfected HEK293FT cells was performed with Rhod-2, and light-induced IP 3 production was assessed by an immunoassay (Cisbio) for inositol-1-phosphate (IP 1 ), a degradation product of IP 3 .
Embryonic stem cell generation and differentiation
G4 mouse embryonic stem (ES) cells were stably transfected with the CAG-melanopsin-IRES-GFP plasmid and differentiated in vitro in embryoid bodies (EBs) using the hanging drop method as reported earlier. 16, 23 To exclude unspecific light-induced effects, mouse ES cells and HEK293FT cells transfected with a plasmid for expression of the enhanced GFP under control of the chicken b-actin promoter (CAG-GFP) served as controls. T. Beiert et al.
Analysis of pacemaking and optical stimulation
The frequency of spontaneously beating EBs was analysed by video microscopy as previously reported, 16 using a dark setting and infrared light for imaging to avoid melanopsin activation by ambient or microscope light. For statistics, the change of frequency during illumination was normalized to baseline frequency before light application. To determine the localization of the leading pacemaker in a syncytium of cardiomyocytes, local field potentials were recorded with microelectrode arrays and conduction analysis was performed as described previously. 16 Cells were stimulated with blue light (470 nm) using a temperaturecontrolled LED module as described earlier, 16 and light was attenuated with a neutral density filter.
Ca 21 imaging
Rhod-2 and Fura-2 were used for Ca 2+ 
Immunohistochemistry and quantitative PCR
Immunostainings were performed according to standard protocols as reported earlier. 16 Quantitative PCR was performed using TaqMan Gene Expression Assays (Applied Biosystems) and a Rotor-Gene 6000 quantitative PCR cycler (Corbett Life Science) as previously reported. 24 3. Results
Characterization of melanopsin function in HEK293FT cells
We chose melanopsin for light-induced activation of the G q -signalling cascade ( Figure 1A ) because of the robust activation of G q proteins by relatively low light intensities, 21, 22 compared with other optogenetic proteins. 16, 18 To identify melanopsin-expressing cells, we generated a new plasmid for co-expression of melanopsin and GFP with an internal ribosomal entry site under control of the CAG promoter ( Figure 1B) . We have chosen this ubiquitous promoter, because it provides very high expression levels especially in muscle cells. 25 To test the functionality of the generated construct, HEK293FT cells were transfected and melanopsin-expressing cells could be identified by GFP fluorescence. Melanopsin function was validated by measuring IP 1 , a degradation product of IP 3 , with an immunoassay in cells without and after 5 min of illumination (2.9 mW/mm 2 ). In the absence of retinal aldehydes, lightinduced elevation of IP 1 concentration could not be detected. However, after pre-treatment with 1 mmol/L of all-trans-retinal (ATR) or 11-cis-retinal, a robust light-induced increase of intracellular IP 1 concentration could be observed ( Figure 1C ). We found that supplement of ATR was slightly more effective for light-induced IP 1 increase than that of 11-cis-retinal ( Figure 1C ). Therefore, further experiments were performed after pre-treatment of cells with 1 mmol/L of ATR. Importantly, control HEK293FT cells exclusively expressing GFP did not show lightinduced elevation of IP 1 levels ( Figure 1D ).
To analyse intact downstream G q signalling, Ca 2+ imaging experiments were performed in melanopsin-expressing HEK293FT cells. In these experiments, repetitive light stimulation (10 s, 900 mW/mm 2 ) led to corresponding elevations of intracellular Ca 2+ levels that dropped to baseline after termination of illumination ( Figure 1E ).
Generation of melanopsin-expressing cardiomyocytes
To obtain melanopsin-expressing cardiomyocytes, an ES cell line expressing melanopsin was generated by stable transfection of wild-type ES cells with the CAG-melanopsin-IRES-GFP plasmid ( Figure 1B ). Melanopsin transgenic ES cell colonies showed GFP fluorescence and immunostainings revealed melanopsin expression ( Figure 2A ). These ES cells Optogenetic G q activation in cardiomyocytes were differentiated into cardiomyocytes by generating cell clusters, so called EBs. Spontaneous beating of EBs was detected after Day 7, and experiments were performed at Days 8-9 of differentiation. At this early stage, the phenotype of ES cell-derived cardiomyocytes is relatively uniform and represents early embryonic pacemaker cells, whereas diversification into atrial and ventricular subtypes occurs later. 26, 27 Immunostainings showed clusters of cross-striated a-actinin-positive cardiomyocytes that were positive for GFP and melanopsin ( Figure 2B ). Quantitative PCR revealed that melanopsin expression had no influence on mRNA expression levels of the a-subunit of G q (gnaq), PLC b3 (plcb3) and b4 (plcb4), or IP 3 receptor Type 1 (itpr1) and Type 2 (itpr2) in ES cells (see Supplementary material online, Figure S1A ) and differentiated EBs (see Supplementary material online, Figure S1B ). Importantly, we observed differences neither in basal or ET-1-induced IP 1 levels (see Supplementary material online, Figure S1C ) nor in spontaneous beating frequency (see Supplementary material online, Figure S1D ) or ET-1-induced acceleration of beating rate (see Supplementary material online, Figure S1E ) between melanopsin-expressing and control EBs.
Light-induced G q activation in cardiomyocytes
Brief illumination (60 s, 308.5 nW/mm 2 ) of spontaneously contracting
EBs caused an instantaneous increase in beating frequency, which could be induced repetitively with similar responses ( Figure 2C and Supplementary material online, Video SI). Illumination with the same light intensity did not influence spontaneous beating of control EBs (see Supplementary material online, Figure S2 ). Compared with pharmacological G q activation by ET-1 (60 s, 100 nM), the increase of beating rate induced by illumination (60 s, 308.5 nW/mm 2 ) was much stronger (212.8 + 18.7 vs. 153.6 + 3.3%, n ¼ 4, P ¼ 0.0352, Figure 2D and E) with faster reaching of peak frequencies (10.3 + 1.9 vs. 21.2 + 2.6 s, n ¼ 4, P ¼ 0.0017, Figure 2D and F). To prove that the observed increase in beating frequency was due to G q activation, we blocked different parts of the signalling cascade. Inhibition of PLC by U-73122 (10 mmol/L) led to a significant decrease of light-induced acceleration of beating rate from 252.3 + 17.5 to 124.9 + 5.0% (n ¼ 6, P ¼ 0.0008) ( Figure 3A and C ). Application of 2-aminoethoxydiphenyl borate (2-APB, 10 mmol/L) to block IP 3 receptors and canonical transient receptor potential channels reduced the light-evoked increase of beating rate from 239.4 + 30.2 to 129.6 + 17.6% (n ¼ 6, P ¼ 0.0078) ( Figure 3B and C). Blocking of ryanodine receptors with ryanodine (10 mmol/L) 28 had no effect on light-induced increase in beating frequency (253.6 + 36.0 to 272.8 + 40.0%, n ¼ 3, P ¼ 0.7575, Figure 3C ).
To exclude a paracrine-mediated frequency increase due to lightinduced release of hormones from neighbouring melanopsin-expressing cells, single cardiomyocytes were isolated from beating EBs and analysed. These cardiomyocytes were positive for GFP, melanopsin, and a-actinin ( Figure 3D ) and expressed the IP 3 receptor Type 2 ( Figure 3E ). Light application to single spontaneously contracting cardiomyocytes caused an increase in beating frequency similar to that observed in whole EBs ( Figure 3F and Supplementary material online, Video SII), proving a direct effect of light-induced G q activation in cardiomyocytes.
To show melanopsin-induced Ca 2+ release, Ca 2+ imaging was performed with cardiomyocytes from the HL-1 cell line 29 that were transfected to express melanopsin (Supplementary material online, Figure S3B and D) and spontaneous beating rate (see Supplementary material online, Figure S3B and C).
Relationship between melanopsin signalling and light intensity
To analyse the dependence of acceleration in beating rate on light intensity, we stimulated beating EBs with stepwise increasing light intensities from 1.8 to 308.5 nW/mm 2 (60 s, n ¼ 6-7). Increasing light intensities led to more pronounced elevations in beating frequency ( Figure 4A and B). To account for variations in beating frequencies between EBs, the highest peak frequency upon illumination and mean plateau frequency during the last 30 s of light stimulation were normalized to baseline frequency before light application. This analysis showed that illumination with low light intensity (9.1 nW/mm 2 ) led to a small and delayed elevation of beating frequency to 134.2 + 7.2% of baseline. Stimulation with high light intensity (308.5 nW/mm 2 ) resulted in an instantaneous frequency increase to 317.1 + 16.3%, which subsequently declined with a time constant of 14.1 + 3.1 s (n ¼ 6) to a constant plateau frequency of 210.0 + 15.0% ( Figure 4B and C) .
In analogy to dose-response relationships of receptor activation with agonists, we plotted the normalized peak and plateau frequencies against the logarithmic light intensity. This resulted in sigmoid light intensityresponse relationships that could be fitted with Hill equations ( Figure 4C ) to determine the half maximal effective light intensity (ELi50). We found an ELi50 of 41.7 nW/mm 2 when analysing peak frequency and an ELi50 of 29.8 nW/mm 2 for plateau frequency. To quantify the peak-to-plateau relationship, we calculated the ratio between peak and plateau frequency for each individual experiment. Interestingly, this analysis showed that a clear peak in frequency with decline to plateau levels could only be observed at light intensities above 30 nW/mm 2 ( Figure 4D ).
Temporal aspects of melanopsin signalling
Because using light allows instantaneous receptor activation and deactivation, we were able to calculate precise activation and deactivation kinetics of frequency modulation by G q signalling. Using low light intensity (9.1 nW/mm 2 ), the fastest beating rate was reached after 42.4 + 5.5 s, whereas the delay was only 10.2 + 1.7 s when saturating light intensity (308.5 nW/mm 2 ) was applied. This delay from switching on the light to reaching peak frequency depended on the applied light intensity with an ELi50 of 51.8 nW/mm 2 ( Figure 4E) . To determine the effect of illumination duration, light pulses of various lengths were applied at saturating light intensity (308.5 nW/mm 2 ) ( Figure 4F ). Pulse durations of 5 s already led to a maximum increase in beating rate, and the half maximal effective light-pulse duration was 2.1 s (n ¼ 3-6) ( Figure 4G ). To further investigate the observed inactivation with drop from peak to plateau frequency during illumination, we determined recovery from inactivation kinetics using two consecutive stimulations with various (10-90 s) interpulse durations. After stimulation with saturating light intensity (308.5 nW/mm 2 ), almost 90 s delay was required for full recovery ( Figure 4H ) and the time constant for recovery from inactivation was 50.6 s (see Supplementary material online, Figure S4) . Importantly, at lower light intensity (39.4 nW/mm 2 ), no inactivation was observed since two consecutive stimulations with 10 s interpulse delay resulted in a similar response ( Figure 4H ). After termination of illumination, beating frequency returned to baseline levels with an exponential decay and a time constant of 27.1 + 2.5 s (n ¼ 4, determined after stimulation with 308.5 nW/mm 2 ).
Irregular beating after melanopsin activation
Optical G q activation by high light intensity stimulation was followed by irregular beating in the form of abrupt accelerations of beating rate, prolonged pauses, and bigeminal rhythms (continuous alternation of short and long cycles) ( Figure 5A ). Interestingly, this occurred after termination of illumination and persisted for up to 4 min. To quantify irregular beating, we analysed the coefficient of variation (CV) of interbeat intervals after termination of illumination ( Figure 5B ) (for details see Supplementary material online, methods). We found that this value depended on the applied light intensity with an ELi50 of 42.9 nW/mm 2 , and that irregular beating only occurred after light intensities above 30 nW/mm 2 ( Figure 5C ). There seems to be a correlation between peak frequency and the occurrence of irregular beating because plotting the peak frequency of each light intensity vs. the corresponding arrhythmia index (CV) showed a linear relationship with a correlation coefficient R 2 of 0.91 ( Figure 5D ).
Local stimulation of melanopsin
Local activation of G q signalling using receptor agonists is technically challenging because of diffusion after application. In contrast, optogenetic G q activation by focused light enables locally restricted G q stimulation. To investigate the relevance of spatially confined G q activation, whole EBs were plated on microelectrode arrays that allow recording of local field potentials from beating cardiomyocytes ( Figure 6A ). Latency analysis of field potentials was used to identify the leading pacemaker site during spontaneous beating and the direction of conduction within the syncytium of electrically coupled cardiomyocytes ( Figure 6B ). Illumination of a small area (Ø 650 mm, 308.5 nW/mm 2 ) opposite of the leading pacemaker site caused an increase in beating frequency ( Figure 6A, enlargement) . Importantly, latency analysis showed that, during illumination, pacemaking was initiated at the illuminated site and electrical activity was conducted to non-illuminated areas ( Figure 6C ).
Discussion
The aim of this study was to establish melanopsin as a new optogenetic tool in cardiovascular research and to use it to investigate the physiological role of G q signalling in pacemaking of cardiomyocytes at an early developmental stage. The advantages of optogenetic approaches are manifold because they allow non-contact stimulation of a specific cell type with down to millisecond and micron-scale resolution.
Side effects of melanopsin overexpression
Overexpression of light-sensitive proteins might modulate or disturb the native intracellular signalling machinery even without illumination because of protein binding or other overexpression artefacts. Therefore, we have analysed the gene expression levels of major components of the G q -signalling cascade, the baseline and agonist-induced IP 3 production, as well as the spontaneous and agonist-stimulated beating rates. We found that all these parameters were similar in melanopsin and control ES cells and EBs. Because we did not analyse protein expression, we cannot fully exclude minor side effects on the native G q -signalling cascade by overexpression of exogenous melanopsin. However, this is unlikely because baseline frequency and agonistinduced modulation of pacemaking are not altered by melanopsin expression.
Modulation of pacemaking by light-induced G q stimulation
Ca 2+ oscillations are involved in the regulation of pacemaking in cardiomyocytes derived from early embryonic hearts 6, 9, 10 or from ES cells. 7, 8 These Ca 2+ oscillations originate from intracellular stores and are translated into membrane depolarization by the sodium -calcium exchanger leading to action potential generation and spontaneous beating. 6, 9 Hyperpolarization-activated cyclic nucleotide (HCN)-gated channels play a minor role at this early stage, because their blockage has no or little effect on beating frequencies in vitro 7, 9 and blockage or genetic ablation of HCN channels does not completely inhibit spontaneous beating of early (E9.5) hearts in vivo.
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In this study, we analysed EBs on Days 8-9 of differentiation in which cardiomyocytes are in an early developmental stage with a relatively uniform early pacemaker-like phenotype. 26, 27 Light-induced G q activation increased the firing rate of spontaneously beating EBs. This effect was highly specific to melanopsin and G q signalling, because it was not observed in control cardiomyocytes and it was attenuated by blockage of components of the G q -signalling cascade. Using slowly beating HL-1 cardiomyocytes, we were able to demonstrate light-induced elevation of diastolic Ca 2+ that further supports G q -induced Ca 2+ release from IP 3 -sensitive stores. Paracrine effects through liberation of hormones from neighbouring cells in the multicellular EB could be excluded because isolated single ES cell-derived cardiomyocytes showed a similar light-induced frequency increase. We conclude that light-induced stimulation of melanopsin induces PLC activity and IP 3 generation that leads to Ca 2+ release by IP 3 receptors in early ES cell-derived cardiomyocytes. This, in turn, enhances spontaneous Ca 2+ oscillations and thereby increases spontaneous pacemaking activity. This is fully in line with previous reports, which showed reduced or abolished beating in the presence of the IP 3 receptor antagonists Xestospongin C 7 and 2-APB 6,8,9 as well as the PLC blocker U-73122. 8 In addition, G q -coupled agonists like phenylephrine and ET-1 8, 10 or direct administration of a membrane permeable form of IP 3 9 caused an increase in beating frequency in embryonic cardiomyocytes. This principle also seems to be important during embryonic pacemaking in vivo because embryonic hearts at very early developmental stages show high levels of endogenous ET-1 and the blockage of ET receptors induces bradycardic arrhythmia in utero. 10 Since cells of the sinus node express IP 3 receptors, 5 G q activation could influence pacemaking also in the adult heart. Furthermore, the G q -coupled agonist ET-1 is known to induce arrhythmogenic Ca 2+ responses in ventricular and atrial cardiomyocytes, 13, 14 which were abolished in cardiomyocytes from IP 3 receptor 2 knockout mice. 14 Because expression of IP 3 receptors is up-regulated in cardiac disease, G q -induced Ca 2+ release becomes more important in such pathological states. 5 To investigate these mechanisms in the future, cell-specific expression of melanopsin would enable the selective activation of G q signalling in cardiomyocytes without affecting other cell types in the heart or body.
Irregular beating after high-intensity G q stimulation
We observed that high light intensity stimulation of the G q -signalling cascade perturbed regular rhythmic pacemaking in melanopsinexpressing EBs for prolonged periods of time (up to 4 min) after termination of illumination. We did not observe irregular beating during or after brief pharmacological G q stimulation with ET-1. Presumably this is because the ET-1-induced frequency response was comparable with low intensity light stimulation, which also did not induce irregular beating. It therefore seems likely that maximal optogenetic stimulation of highly overexpressed melanopsin stimulates the G q -signalling pathway to a larger and eventually non-physiological extent than using an endogenous receptor. Therefore, transferring this observation to the pathophysiology of arrhythmias has to be done with caution.
However, we speculate that overexpression of an optogenetic G q protein-coupled receptor might be useful to 'simulate' effects of enhanced receptor expression and higher activity of G q signalling, which is known to occur in cardiac pathology. 5 
Temporal aspects and inactivation of light-induced G q signalling
Illumination of melanopsin allows repetitive and instantaneous on-and off-switching of the G q -signalling pathway, which cannot be performed with agonists with similar temporal precision. We used this to determine the activation and deactivation kinetics of the G q -signalling cascade in pacemaking of cardiomyocytes. Using saturating light intensity, we found that an increase in beating frequency started almost instantaneously, peak frequency was reached within 10 s and light-pulse durations as short as 5 s were sufficient for maximal response. Interestingly, high-intensity stimulation led to a biphasic frequency response with a peak frequency that inactivated to a sustained plateau frequency. This inactivation affects subsequent stimulations and recovers with a time constant of 50 s. In contrast, low intensity stimulation does neither generate a biphasic response nor induce prolonged inactivation. The mechanism for the high light intensity-induced inactivation can be explained by either (i) desensitization of melanopsin, (ii) negative feedback and inactivation of various parts of the G q -signalling cascade ('biochemical adaptation'), or (iii) reduction of IP 3 receptor activity by elevated Ca 2+ levels because of the bell-shaped dependence on intracellular Ca 2+ concentrations. 31 The observation that peak frequency with inactivation as well as prolonged irregular beating occurs only at highintensity stimulation suggests a similar mechanism underlying both effects. This assumption makes a negative feedback on the G q -signalling cascade the more likely explanation because after termination of illumination desensitized melanopsin does not interfere with pacemaking and Ca 2+ has returned to basal levels. This interpretation is in line with the proposed mechanism ('biochemical adaptation') for desensitization and light adaption of the melanopsin-based phototransduction cascade of intrinsic photosensitive retinal ganglion cells. 32 
Dose -response relationships and light sensitivity
Generation of dose-response relationships using receptor agonists requires precise agonist concentrations at the cells of interest which depends on perfusion and diffusion characteristics, especially in multicellular preparations. We found that light-induced frequency increase was highly reproducible even after repetitive stimulations. This allowed accurate stimulation with various light intensities and thereby a straightforward analysis of dose-response relationships. In analogy to the half maximal effective concentration for receptor agonists, we defined ELi50 as the half maximal effective light intensity for a specific effect. We found that ELi50 was only 41.7 and 29.8 nW/mm 2 for reaching peak and plateau frequencies, respectively.
These values are 10 4 -10 5 times lower than the light intensities required for optogenetic stimulation of channelrhodopsin2 in cardiomyocytes ( 1 mW/mm 2 ). 16 The high light sensitivity of melanopsin poses some disadvantages in general handling of cells and performing of experiments, but also has great advantages especially when used in vivo. For detailed discussion, see technical note in Supplementary material online. 
Spatial resolution
We have shown that focused light can be used for locally confined G q activation within a functional syncytium of melanopsin-expressing cardiomyocytes, and that this is sufficient to induce local pacemaking. Thus, at the early developmental stage investigated here, the levels of G q activity seem to be a potent factor for determining the leading pacemaker. Localized G q activation cannot be achieved with pharmacological agonists because they diffuse and thereby make determination of exact borders of stimulation impossible. Being able to locally activate the G q cascade might be very useful to investigate the location of G q -sensitive cardiomyocytes in the developing heart in vivo, or to investigate IP 3 -dependent communication via gap junctions between endothelial and/ or smooth muscle cells in the vascular wall.
Outlook and potential applications in vivo
Channelrhodposin2 and other optogenetic tools have been extensively used for in vivo applications mainly in the brain but also in the heart. 16, 17 One important feature of optogenetics is the possibility of cell typespecific expression when using specific promoters. Melanopsin, therefore, enables investigation of cell type-specific effects of G q -signalling in vivo, which cannot be performed with agonists applied into the blood circulation because they act globally and on all cell types expressing the respective receptor. Importantly, serum ATR levels seem to be sufficient for melanopsin function and exogenous ATR is not required in vivo. 22 One cardiovascular example highlighting the importance of cell specificity is the vascular system, where endothelial G q activation causes vasodilation and G q activation in smooth muscle cells induces vasoconstriction. Furthermore, melanopsin transgenic mice could be used to study the importance of G q signalling in cardiac pacemaking in vivo. In such experiments, cell-specific expression in cardiomyocytes would exclude side effects of systemically applied G q -coupled receptor agonists on endothelial and smooth muscle cells that might influence coronary perfusion. Taken together, optogenetic G q activation corroborates the importance of the G q -signalling cascade in pacemaking in cardiomyocytes. Furthermore, melanopsin will be a very useful novel optogenetic tool to analyse cell type-specific effects of the G q -signalling cascade in the cardiovascular system with high spatial and temporal resolution in vitro and in vivo.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
